Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.
Sato Y, Rahman MM, Haneda M, Tsuyama T, Mizumoto T, Yoshizawa T, Kitamura T, Gonzalez FJ, Yamamura KI, Yamagata K. Sato Y, et al. Biochim Biophys Acta Mol Basis Dis. 2020 Nov 1;1866(11):165898. doi: 10.1016/j.bbadis.2020.165898. Epub 2020 Jul 22. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32711050 Free PMC article.
Autoimmune Polyglandular Syndrome Type 3 Complicated with IgG4-related Disease.
Murata Y, Haneda M, Miyakawa N, Nishida S, Kajihara N, Maeda S, Ono K, Hanatani S, Igata M, Takaki Y, Motoshima H, Kishikawa H, Araki E. Murata Y, et al. Intern Med. 2024 Feb 1;63(3):425-431. doi: 10.2169/internalmedicine.1270-22. Epub 2023 Jun 21. Intern Med. 2024. PMID: 37344441 Free PMC article.
Intensified multifactorial intervention leads to long-term benefit on kidney outcomes in advanced diabetic kidney disease: A 10-year follow-up of the DNETT-Japan trial.
Shikata K, Miyamoto S, Haneda M, Hosoi H, Sakamoto K, Suzuki Y, Suzuki D, Ishida H, Akai H, Tomino Y, Uzu T, Nishimura M, Kuramoto H, Yoshida M, Ogawa D, Ninomiya T, Makino H; Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan) collaborative group. Shikata K, et al. Among authors: haneda m. J Diabetes Investig. 2026 Jul 14:10.1111/jdi.70392. doi: 10.1111/jdi.70392. Online ahead of print. J Diabetes Investig. 2026. PMID: 42447130 Free PMC article.
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Zhou J, Williams C, Staplin N, Judge PK, Mayne KJ, Agrawal N, Arimoto R, Green JB, Cherney DZI, Tuttle KR, Leal J, Clarke P, Emberson JR, Preiss D, Wanner C, Landray MJ, Baigent C, Haynes R, Herrington WG, Mihaylova B; EMPA-KIDNEY Collaborative Group. Zhou J, et al. EClinicalMedicine. 2025 Jul 8;85:103338. doi: 10.1016/j.eclinm.2025.103338. eCollection 2025 Jul. EClinicalMedicine. 2025. PMID: 40686671 Free PMC article.
Clinicopathological and molecular characterization of KRAS wild-type pancreatic ductal adenocarcinomas reveals precursor lesions with oncogenic mutations and fusions in RAS pathway genes.
Toriyama K, Masago K, Shibata N, Haneda M, Kuwahara T, Natsume S, Kobayashi S, Fujita Y, Sasaki E, Yamao K, Kawashima H, Shimizu Y, Hara K, Yatabe Y, Hosoda W. Toriyama K, et al. Among authors: haneda m. J Pathol. 2025 Jul;266(3):337-351. doi: 10.1002/path.6432. Epub 2025 May 2. J Pathol. 2025. PMID: 40317966 Free PMC article.
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Mayne KJ, Sardell RJ, Staplin N, Judge PK, Zhu D, Sammons E, Cherney DZI, Cheung AK, Maggioni AP, Nangaku M, Rossello X, Tuttle KR, Ihara K, Iwata T, Wanner C, Emberson J, Preiss D, Landray MJ, Baigent C, Haynes R, Herrington WG; EMPA-KIDNEY Collaborative Group. Mayne KJ, et al. Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1119-1129. doi: 10.2215/CJN.0000000000000498. Epub 2024 Jun 27. Clin J Am Soc Nephrol. 2024. PMID: 40179340 Free PMC article. Clinical Trial.
478 results